Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 1 2

Status

Recruiting 3Completed 1

Sponsor Class

OTHER 2OTHER_GOV 1NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 53Gynecologic 52Genitourinary 35Gastrointestinal 23Thoracic 19Sarcoma 13Other solid neoplasm 11CNS 11Tumor-Agnostic 8Lymphoid 5Endocrine 5NET 4Head & Neck 4Other hematologic neoplasm 3Plasma cell 2Myeloid 2Dermatologic 2Classical hematology 2

Conditions

Neuroendocrine Tumors 4Thymoma 1Sarcoma, Synovial 1Recurrence 1Pheochromocytoma 1Paraganglioma 1Osteosarcoma 1Neuroblastoma 1Mesothelioma 1Meningioma 1Medulloblastoma 1Glioma 1Glioblastoma 1Esthesioneuroblastoma, Olfactory 1Carcinoid Tumor 1Adrenal Gland Neoplasms 1Adrenal Cortex Neoplasms 1

Interventions

lutetium Lu 177 dotatate 29Magnetic Resonance Spectroscopy 15Everolimus 10pembrolizumab 9Specimen Handling 9cabozantinib 7Nivolumab 7Lutetium-177 6surufatinib 5lenvatinib 5Octreotide 5Capecitabine 5177Lu-octreotide, DOTA(0)-Tyr(3)- 5olaparib 4lanreotide 4gallium Ga 68 dotatate 4amino-acid, glucose, and electrolyte solution 4X-Rays 4Lutetium 4Ipilimumab 4Injections 4Fluorodeoxyglucose F18 4copper dotatate CU-64 3atezolizumab 3Temozolomide 3Ga(III)-DOTATOC 3Cyclophosphamide 3Carboplatin 3pasireotide 2fludarabine phosphate 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
olaparib × NET × 1 year × Clear all
NCT04086485 2026-05-22

Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)

National Institutes of Health Clinical Center (CC)

Phase 1/2 Recruiting
56 enrolled
EndocrineNET

Carcinoid Tumor, Neuroendocrine Tumors

NCT04375267 2026-04-14

LuPARP

Vastra Gotaland Region

Phase 1 Completed
18 enrolled
EndocrineNETOther solid neoplasmThoracic

Mesothelioma, Thymoma, Neuroendocrine Tumors

NCT06607692 2026-04-14

LUPARPED

Fundación de investigación HM

Phase 1/2 Recruiting
25 enrolled
CNSEndocrineNETSarcoma

Adrenal Cortex Neoplasms, Adrenal Gland Neoplasms, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neuroblastoma, Paraganglioma, Pheochromocytoma, Recurrence, Osteosarcoma, Sarcoma, Synovial, Esthesioneuroblastoma, Olfactory, Neuroendocrine Tumors

NCT05870423 2025-06-05

PRRT-PARPi

Erasmus Medical Center

Phase 1 Recruiting
24 enrolled
EndocrineNET

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡